Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PMS1 protein homolog 1 (PMS1) is a member of the MutL homolog family and a vital component of the eukaryotic DNA mismatch repair (MMR) system (UniProt P54277). It functions primarily by forming a heterodimer with MLH1, known as MutLβ, which participates in the recognition and repair of DNA base-pair mismatches and insertion-deletion loops generated during DNA replication (GeneCards; Wikipedia). Beyond its canonical role in maintaining genomic stability, PMS1 has recently emerged as a significant therapeutic target for Huntington's disease and other trinucleotide repeat expansion disorders (Nature Communications, 2024, 15:3182). Research indicates that PMS1 is a key driver of somatic CAG repeat expansion, and its downregulation can slow the progression of these neurodegenerative conditions (Nature Communications, 2024, 15:3182). Small-molecule splice modulators, including branaplam and risdiplam, have been shown to target PMS1 by inducing the inclusion of a premature stop codon-containing pseudoexon, leading to reduced protein expression (BioWorld, 2025; Nature Communications, 2024). While therapeutic modulation of PMS1 offers a novel approach to treating repeat expansion diseases, it also presents challenges such as the potential for increased systemic mutation rates and an associated risk of malignancies like Lynch syndrome (GeneCards; PubMed 8128251).
Splice modulation via the induction of a frame-shifting pseudoexon containing a premature stop codon, leading to the downregulation of PMS1 protein levels (Nature Communications, 2024, 15:3182; BioWorld, 2025).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PMS1 protein homolog 1 (PMS1) (PMS1).